A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.

Krajewski, Wojciech

A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer. [electronic resource] - Urologic oncology 06 2020 - 606-607 p. digital

Publication Type: Letter; Comment

1873-2496

10.1016/j.urolonc.2020.03.027 doi


Administration, Intravesical
Antineoplastic Agents
BCG Vaccine
Humans
Prospective Studies
Urinary Bladder Neoplasms